Abstract
Myocardial ischemia-reperfusion (IR) injury during acute myocardial infarction or open-heart surgery would promote oxidative stress, leading to the accumulation of reactive aldehydes that cause cardiac damage. It has been well demonstrated that aldehyde dehydrogenase (ALDH)-2 is an important cardioprotective enzyme for its central role in the detoxification of reactive aldehydes. ALDH2 activation by small molecule activators is a promising approach for cardioprotection for myocardial IR injury.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hanson MA, Fareed MT, Argenio SL, Agunwamba AO, Hanson TR (2013) Coronary artery disease. Prim Care 40:1–16. https://doi.org/10.1016/j.pop.2012.12.001
Mozaffarian D et al (2015) Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 131:e29–e322. https://doi.org/10.1161/CIR.0000000000000152
Lejay A et al (2016) Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. J Mol Cell Cardiol 91:11–22. https://doi.org/10.1016/j.yjmcc.2015.12.020
Hill BG, Bhatnagar A (2009) Beyond reactive oxygen species: aldehydes as arbitrators of alarm and adaptation. Circ Res 105:1044–1046. https://doi.org/10.1161/CIRCRESAHA.109.209791
Milei J, Grana D (2007) R., Forcada, P. & Ambrosio, G. mitochondrial oxidative and structural damage in ischemia-reperfusion in human myocardium. Current knowledge and future directions. Front Biosci 12:1124–1130
White CW et al (2016) Avoidance of profound hypothermia during initial reperfusion improves the functional recovery of hearts donated after circulatory death. Am J Transplant 16:773–782. https://doi.org/10.1111/ajt.13574
Sepehri A et al (2014) The impact of frailty on outcomes after cardiac surgery: a systematic review. J Thorac Cardiovasc Surg 148:3110–3117. https://doi.org/10.1016/j.jtcvs.2014.07.087
Roger VL et al (2012) Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 125:188–197. https://doi.org/10.1161/CIR.0b013e3182456d46
Wong ND (2014) Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol 11:276–289. https://doi.org/10.1038/nrcardio.2014.26
Bonsu KO, Owusu IK, Buabeng KO, Reidpath DD, Kadirvelu A (2016) Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies. Therap Clin Risk Manag 12:887–906. https://doi.org/10.2147/tcrm.s106065
Zhang Y, Ren J (2011) ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications. Pharmacol Ther 132:86–95. https://doi.org/10.1016/j.pharmthera.2011.05.008
Yin G et al (2016) ALDH2 polymorphism is associated with fasting blood glucose through alcohol consumption in Japanese men. Nagoya J Med Sci 78:183–193
Yokoyama A et al (2013) Genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and liver cirrhosis, chronic calcific pancreatitis, diabetes mellitus, and hypertension among Japanese alcoholic men. Alcohol Clin Exp Res 37:1391–1401. https://doi.org/10.1111/acer.12108
Dakeishi M, Murata K, Sasaki M, Tamura A, Iwata T (2008) Association of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 genotypes with fasting plasma glucose levels in Japanese male and female workers. Alcohol Alcohol 43:143–147. https://doi.org/10.1093/alcalc/agm173
Takagi S et al (2002) Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertens Res 25:677–681
Xu F et al (2011) Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome. J Cell Mol Med 15:1955–1962. https://doi.org/10.1111/j.1582-4934.2010.01181.x
Jo SA et al (2007) A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men. Clin Chim Acta 382:43–47. https://doi.org/10.1016/j.cca.2007.03.016
Bian Y et al (2010) The polymorphism in aldehyde dehydrogenase-2 gene is associated with elevated plasma levels of high-sensitivity C-reactive protein in the early phase of myocardial infarction. Tohoku J Exp Med 221:107–112
Broeckel U et al (2002) A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Gen 30:210–214. https://doi.org/10.1038/ng827
Yamada Y et al (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916–1923. https://doi.org/10.1056/NEJMoa021445
Hvidtfeldt UA et al (2010) Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation 121:1589–1597. https://doi.org/10.1161/circulationaha.109.887513
Huang B et al (2012) Adverse cardiovascular effects of concomitant use of proton pump inhibitors and clopidogrel in patients with coronary artery disease: a systematic review and meta-analysis. Arch Med Res 43:212–224. https://doi.org/10.1016/j.arcmed.2012.04.004
Edenberg HJ (2007) The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health 30:5–13
Li Y et al (2006) Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J Clin Invest 116:506–511. https://doi.org/10.1172/JCI26564
Eng MY, Luczak SE, Wall TL (2007) ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review. Alcohol Res Health 30:22–27
Isse T, Matsuno K, Oyama T, Kitagawa K, Kawamoto T (2005) Aldehyde dehydrogenase 2 gene targeting mouse lacking enzyme activity shows high acetaldehyde level in blood, brain, and liver after ethanol gavages. Alcohol Clin Exp Res 29:1959–1964
Xu F et al (2007) The polymorphism in acetaldehyde dehydrogenase 2 gene, causing a substitution of Glu > Lys (504), is not associated with coronary atherosclerosis severity in Han Chinese. Tohoku J Exp Med 213:215–220
Han H et al (2013) Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis. Gene 526:134–141. https://doi.org/10.1016/j.gene.2013.05.002
Fernandez E et al (2006) Monoamine metabolism and behavioral responses to ethanol in mitochondrial aldehyde dehydrogenase knockout mice. Alcohol Clin Exp Res 30:1650–1658. https://doi.org/10.1111/j.1530-0277.2006.00200.x
Parker JD, Parker JO (1998) Nitrate therapy for stable angina pectoris. N Engl J Med 338:520–531. https://doi.org/10.1056/NEJM199802193380807
Chen Z et al (2005) An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A 102:12159–12164. https://doi.org/10.1073/pnas.0503723102
Ferreira JC, Mochly-Rosen D (2012) Nitroglycerin use in myocardial infarction patients. Circ J 76:15–21
Guo R et al (2008) Evidence for involvement of calcitonin gene-related peptide in nitroglycerin response and association with mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism. J Am Coll Cardiol 52:953–960. https://doi.org/10.1016/j.jacc.2008.05.049
Zhang H et al (2007) The relationship between aldehyde dehydrogenase-2 gene polymorphisms and efficacy of nitroglycerin. Zhonghua Nei Ke Za Zhi 46:629–632
Chen CH et al (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321:1493–1495. https://doi.org/10.1126/science.1158554
Sun A et al (2014) Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy. J Mol Cell Cardiol 71:92–104. https://doi.org/10.1016/j.yjmcc.2014.01.002
Goedde HW et al (1983) Population genetic studies on aldehyde dehydrogenase isozyme deficiency and alcohol sensitivity. Am J Human Gen 35:769–772
Hoshi H et al (2012) Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis. J Bone Miner Res 27:2015–2023. https://doi.org/10.1002/jbmr.1634
Doser TA et al (2009) Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 119:1941–1194. https://doi.org/10.1161/CIRCULATIONAHA.108.823799
Ge W, Guo R, Ren J (2011) AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol. Free Radic Biol Med 51:1736–1748. https://doi.org/10.1016/j.freeradbiomed.2011.08.002
Ge W, Ren J (2012) mTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism. J Cell Mol Med 16:616–626. https://doi.org/10.1111/j.1582-4934.2011.01347.x
Kim J, Chen CH, Yang J, Mochly-Rosen D (2017) Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment. J Biomed Sci 24:33. https://doi.org/10.1186/s12929-017-0338-8
Churchill EN, Disatnik MH, Mochly-Rosen D (2009) Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol 46:278–284. https://doi.org/10.1016/j.yjmcc.2008.09.713
Ebert AD et al (2014) Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Sci Transl Med 6:255 ra130. https://doi.org/10.1126/scitranslmed.3009027
Sun A et al (2014) Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice. J Am Heart Assoc 3:e000779. https://doi.org/10.1161/JAHA.113.000779
Cooper C, Campion G, Melton L (1992) J., 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289
Cui L et al (2010) Sublethal total body irradiation leads to early cerebellar damage and oxidative stress. Curr Neurovasc Res 7:125–135
Dandre F, Cassaigne A, Iron A (1995) The frequency of the mitochondrial aldehyde dehydrogenase I2 (atypical) allele in Caucasian, oriental and African black populations determined by the restriction profile of PCR-amplified DNA. Mol Cell Probes 9:189–193. https://doi.org/10.1006/mcpr.1995.0030
Ma H, Guo R, Yu L, Zhang Y, Ren J (2011) Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur Heart J 32:1025–1038. https://doi.org/10.1093/eurheartj/ehq253
Becker LB (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61:461–470. https://doi.org/10.1016/j.cardiores.2003.10.025
Gong D et al (2012) Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury. Cardiovasc Toxicol 12:350–358. https://doi.org/10.1007/s12012-012-9179-6
Ohsawa I et al (2008) Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity. J Neurosci 28:6239–6249. https://doi.org/10.1523/JNEUROSCI.4956-07
Yu BP (2005) Membrane alteration as a basis of aging and the protective effects of calorie restriction. Mech Ageing Dev 126:1003–1010. https://doi.org/10.1016/j.mad.2005.03.020
Ota H et al (2006) Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene 25:176–185. https://doi.org/10.1038/sj.onc.1209049
Wu B et al (2016) Aldehyde dehydrogenase 2 activation in aged heart improves the autophagy by reducing the carbonyl modification on SIRT1. Oncotarget 7:2175–2188. https://doi.org/10.18632/oncotarget.6814
Gu C et al (2013) Impaired cardiac SIRT1 activity by carbonyl stress contributes to aging-related ischemic intolerance. PLoS One 8:e74050. https://doi.org/10.1371/journal.pone.0074050
McBeth J et al (2009) Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality. Rheumatology 48:74–77. https://doi.org/10.1093/rheumatology/ken424
Li C et al (2018) Targeting ALDH2 for therapeutic interventions in chronic pain-related myocardial ischemic susceptibility. Theranostics 8:1027–1041. https://doi.org/10.7150/thno.22414
Kang PF et al (2016) Activation of ALDH2 with low concentration of ethanol attenuates myocardial ischemia/reperfusion injury in diabetes rat model. Oxidative Med Cell Longev 2016:6190504. https://doi.org/10.1155/2016/6190504
Roger VL et al (2011) Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 123:e18–e209. https://doi.org/10.1161/CIR.0b013e3182009701
Fukai M et al (2005) Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. Free Radic Biol Med 38:1372–1381. https://doi.org/10.1016/j.freeradbiomed.2005.02.004
Farout L, Mary J, Vinh J, Szweda LI, Friguet B (2006) Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys 453:135–142. https://doi.org/10.1016/j.abb.2006.02.003
Chen J, Henderson GI, Freeman GL (2001) Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J Mol Cell Cardiol 33:1919–1927. https://doi.org/10.1006/jmcc.2001.1454
Lucas DT, Szweda LI (1999) Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc Natl Acad Sci U S A 96:6689–6693
Bhatnagar A (2006) Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res 99:692–705. https://doi.org/10.1161/01.RES.0000243586.99701.cf
Luo J et al (2007) Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am J Physiol Heart Circ Physiol 293:H3673–H3684. https://doi.org/10.1152/ajpheart.00284.2007
Bellamy CA, Nicely B, Mattice BJ, Teaster R (2008) Comparative analysis of clinical efficacy and cost between University of Wisconsin solution and histidine-tryptophan-ketoglutarate. Prog Transplant 18:166–171
Zhang H, Gong DX, Zhang YJ, Li SJ, Hu S (2012) Effect of mitochondrial aldehyde dehydrogenase-2 genotype on cardioprotection in patients with congenital heart disease. Eur Heart J 33:1606–1614. https://doi.org/10.1093/eurheartj/ehs061
Luckey SW, Tjalkens RB, Petersen DR (1999) Mechanism of inhibition of rat liver class 2 ALDH by 4-hydroxynonenal. Adv Exp Med Biol 463:71–77
Petersen DR, Doorn JA (2004) Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 37:937–945. https://doi.org/10.1016/j.freeradbiomed.2004.06.012
Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A (2009) The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med 6:e50. https://doi.org/10.1371/journal.pmed.1000050
Enomoto N, Takase S, Yasuhara M, Takada A (1991) Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res 15:141–144
Endo J et al (2009) Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. Circ Res 105:1118–1127. https://doi.org/10.1161/CIRCRESAHA.109.206607
Weyker PD, Webb CA, Kiamanesh D, Flynn BC (2013) Lung ischemia reperfusion injury: a bench-to-bedside review. Semin Cardiothorac Vasc Anesth 17:28–43. https://doi.org/10.1177/1089253212458329
Apostolakis E, Filos KS, Koletsis E, Dougenis D (2010) Lung dysfunction following cardiopulmonary bypass. J Card Surg 25:47–55. https://doi.org/10.1111/j.1540-8191.2009.00823.x
Schlensak C et al (2001) Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: assessment of bronchial artery blood flow with fluorescent microspheres. Eur J Cardiothorac Surg 19:326–331
Apostolakis EE, Koletsis EN, Baikoussis NG, Siminelakis SN, Papadopoulos GS (2010) Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. J Cardiothorac Surg 5:1. https://doi.org/10.1186/1749-8090-5-1
Yoon M, Madden MC, Barton HA (2006) Developmental expression of aldehyde dehydrogenase in rat: a comparison of liver and lung development. Toxicol Sci 89:386–398. https://doi.org/10.1093/toxsci/kfj045
Stewart MJ, Malek K, Crabb DW (1996) Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J Investig Med 44:42–46
Ding J et al (2016) Alda-1 attenuates lung ischemia-reperfusion injury by reducing 4-Hydroxy-2-Nonenal in alveolar epithelial cells. Crit Care Med 44:e544–e552. https://doi.org/10.1097/CCM.0000000000001563
Lin YP, Cheng TJ (2002) Why can’t Chinese Han drink alcohol? Hepatitis B virus infection and the evolution of acetaldehyde dehydrogenase deficiency. Med Hypotheses 59:204–207
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ding, J., Yang, Z., Ma, H., Zhang, H. (2019). Mitochondrial Aldehyde Dehydrogenase in Myocardial Ischemic and Ischemia-Reperfusion Injury. In: Ren, J., Zhang, Y., Ge, J. (eds) Aldehyde Dehydrogenases. Advances in Experimental Medicine and Biology, vol 1193. Springer, Singapore. https://doi.org/10.1007/978-981-13-6260-6_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-6260-6_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6259-0
Online ISBN: 978-981-13-6260-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)